(TheNewswire)
Calgary, Alberta – June 25, 2024 – TheNewswire – nDatalyze Corp. (“ NDAT ” or the “Corporation”)(CSE:NDAT) (OTC:NDATF) is pleased to update the operations of its 100%-ownedMindbalanced, Inc. subsidiary.
The following is for operationalupdate purposes only and is not necessarily material.
Joshua Hill, NDAT and MindbalancedInc. President, reports: “ Our overall solutioninvolves collaborative partnerships with mental health-relatedfacilities, clinics, and clinicians seeking effective and personalizedtreatment plans for drug-resistant patients. We consult with theentire program, and our revenue-sharing business model benefitscustomers by saving time, providing state-of-the-art tools, offeringpersonalized treatment protocols, and adding an additional revenuestream. We anticipate significant growth in revenues from private andpublic medical insurance programs as mental health benefits areincorporated into more insurance plans. Lastly, we anticipate addingsubstantial biometric, DNA, and TMS treatment response data to ourdatabase. This data will be instrumental in advancing clinicalresearch and developing personalized treatment protocols, ultimatelyleading to improved patient outcomes.”
Mindbalanced’s current sales pipeline includes twolarge healthcare facilities in the Southeast US catering to a patientbase of over 2,000 candidates; a major psychiatric hospital in SouthFlorida; and a partnering network in Alabama that serves over 10,000active patients. The “prospect-to-revenue” cycle is expected to beapproximately 120 dayswith Mindbalanced being well into the cycle with multiple prospects. While none of these prospectsare yet under contract they are disclosed to inform investors as towhat Mindbalanced’s prospecting activity looks like.
Joshua Hill, NDAT and MindbalancedInc. President, adds: Leading manufacturers ofTMS often use a consumable model that imposes a significant financialstrain on facilities thereby reducing patient access to thesetreatments. In contrast, our non-consumable model means facilities donot pay per treatment, making TMS more accessible and affordable forpatients. Our aim is to onboard and launch a new facility every thirtydays. This strategy allows the implementation team time to thoroughlyconsult with potential partners and their staff, ensuring a seamlessand effective integration of Mindbalanced’s TMS programs.”
For Further Information, pleasecontact:
Joshua Hill, President
Email: josh@mindbalanced.org
Tel: (786) 714-4811
Mindbalanced Website: https://mindbalanced.org
YMI Website: https://ymihealth.ca
nDatalyze Website: https://www.ndatalyze.com
About Mindbalanced, Inc.: Mindbalanced’s vision is to redefine mentalhealthcare through an integrative, personalized approach leveragingcutting edge technology and non-invasive treatment protocols. Byharnessing evidence-based data we aim to predict and enhance mentalwellbeing, taking into account individual predispositions andenvironmental factors thereby fostering healthier and more fulfillinglives for all.
About YMI: YMIuses evidence-based, objective data from whole life experiences topredict individual mental states over time and applies this knowledgetowards a fuller understanding of how mental health develops, and howto improve mental wellbeing. YMI combines supervised machine-learningwith a proprietary Reference Database to predict an individual’spredisposition toward a variety of common mental conditions, bothcurrent and forward in time. YMI is poised torevolutionize mental health diagnoses while ensuring a sustainablerevenue stream. By strategically addressing the causes ofmisdiagnosis, establishing credibility through clinical studies, andtargeting key markets, YMI aligns both societal impact and financialsuccess.
Neither the Canadian Securities Exchange nor itsRegulation Services Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release. This news release does notconstitute an offer to sell or a solicitation of an offer to sell anyof the securities in the United States. The securities have not beenand will not be registered under the United States Securities Act of1933, as amended (the "U.S. Securities Act") or any statesecurities laws and may not be offered or sold within the UnitedStates or to U.S. Persons unless registered under the U.S. SecuritiesAct and applicable state securities laws or an exemption from suchregistration is available. The information in this news releaseincludes certain information and statements about management's view offuture events, expectations, plans and prospects that constituteforward looking statements. These statements are based uponassumptions that are subject to significant risks and uncertainties.Because of these risks and uncertainties and as a result of a varietyof factors, the actual results, expectations, achievements orperformance may differ materially from those anticipated and indicatedby these forward-looking statements. Any number of factors could causeactual results to differ materially from these forward-lookingstatements as well as future results. Although the Corporationbelieves that the expectations reflected in forward looking statementsare reasonable, it can give no assurances that the expectations of anyforward-looking statements will prove to be correct. Except asrequired by law, the Corporation disclaims any intention and assumesno obligation to update or revise any forward-looking statements toreflect actual results, whether as a result of new information, futureevents, changes in assumptions, changes in factors affecting suchforward-looking statements or otherwise.
Copyright (c) 2024 TheNewswire - All rights reserved.